EFFECTS OF THE MTOR INHIBITOR RAPAMYCIN IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A PHASE I/II TRIAL

(1) Department of Gastroenterology and Hepatology

(2) Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria



This item was part of the BILIARY II session at Gastro 2009 UEGW/WCOG London (17th UEGW)

Categorisation:

  • Format
    • Poster
  • Language
    • English
  • Year
    • 2009